Structure of the homodimeric androgen receptor ligand-binding domain

Citations Over TimeTop 10% of 2017 papers

Abstract

The androgen receptor (AR) plays a crucial role in normal physiology, development and metabolism as well as in the aetiology and treatment of diverse pathologies such as androgen insensitivity syndromes (AIS), male infertility and prostate cancer (PCa). Here we show that dimerization of AR ligand-binding domain (LBD) is induced by receptor agonists but not by antagonists. The 2.15-Å crystal structure of homodimeric, agonist- and coactivator peptide-bound AR-LBD unveils a 1,000-Å2 large dimerization surface, which harbours over 40 previously unexplained AIS- and PCa-associated point mutations. An AIS mutation in the self-association interface (P767A) disrupts dimer formation in vivo, and has a detrimental effect on the transactivating properties of full-length AR, despite retained hormone-binding capacity. The conservation of essential residues suggests that the unveiled dimerization mechanism might be shared by other nuclear receptors. Our work defines AR-LBD homodimerization as an essential step in the proper functioning of this important transcription factor.

Related Papers

• → Androgen receptor and MYC equilibration centralizes on developmental super-enhancer(2021)73 cited
• → PRIC295, a Nuclear Receptor Coactivator, Identified from PPAR-Interacting Cofactor Complex(2010)15 cited
• → Homologous Androgen Receptor Up-Regulation in Osteoblastic Cells May Be Associated with Enhanced Functional Androgen Responsiveness*(1999)33 cited
• → Androgen receptor: role in the female lower vertebrate reproduction(2010)
• → THE PHYSIOPATHOLOGICAL ROLES OF ANDROGENS IN MOTONEURONS(2020)